$19MSeries A, 5 March 2026
Builds operating system for clinically intensive therapy delivery outside academic centers
- Amount
- $19M
- Stage
- Series A
- Announced
- 5 March 2026
- Lead
- RA Capital Management
- Other investors
- Cencora Ventures, Oncology Ventures
- Use of funds
- Builds operating system for clinically intensive therapy delivery outside academic centers
- Checked
- Announced by the company
- Sources
- NexCure raises $19M biospace.com
NexCure raises $19M pulse2.com